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Compound 1a: To a solution of rhodamine Q (0.50 g, 1.2 mmol) and 2-(N-methylamino)ethanol (0.44 g, 0.47 mL, 5.9 mmol) 
in N,N-dimethylacetamide (10 mL) was added HATU (0.61 g, 1.6 mmol), and the mixture was stirred at room temperature for 
19 h, followed by the addition of HATU (0.30 g, 0.79 mmol). After 17 h, the solvent was evaporated in vacuo at ambient 
temperature, and the product was isolated by chromatography on SiO2 (130 g) eluting with CH2Cl2/MeOH (10:1, v/v), yield 
0.54 g (96%) as a bordeaux solid. 1H NMR (300 MHz, [D6]-DMSO, ppm): δ = 1.80 (br. s, (CH2)CH2(CH2), 4 H), 2.67 (br. s, 
ArCH2, 4 H), 2.84 (m, 2 rotamers, NMe, 3 H), 3.18 (m, CH2NCH3, 2 H), 3.41 (br. s, CH2N, 4 H), 3.47 (m, CH2OH, 2 H), 6.65 
(s, H-4/5, 2 H), 6.79 (m, H-1/8, 2 H), 7.39–7.46 (m, H-3', 1 H), 7.59–7.76 (m, H-4'/5'/6', 3 H), 8.77 (br. s, NH, 2 H). ESI-MS, 










Compound 1b: To a solution of rhodamine Q (0.50 g, 1.2 mmol) and methyl 3-(N-methylamino)propionate (0.36 g, 0.34 mL, 
3.1 mmol) in N,N-dimethylacetamide (10 mL) was added HATU (0.61 g, 1.6 mmol), and the mixture was stirred at room 
temperature for 2 days. The solvent was evaporated in vacuo at ambient temperature, and the product was isolated by 
chromatography on SiO2 (150 g) eluting with CH2Cl2/MeOH (10:1, v/v), yield 0.34 g (56%) as a bordeaux solid. 1H NMR 
(300 MHz, [D6]-DMSO, ppm): δ = 1.79 (br. s, (CH2)CH2(CH2), 4 H), 2.04 (t, 3JH,H = 6.9 Hz, (CH2)CH2(CO2CH3), 2 H), 2.65 
(br. s, ArCH2, 4 H), 2.86 (s, NMe, 3 H), 3.31 (t, 3JH,H = 6.9 Hz, CH2NCH3, 2 H), 3.39 (br. s, CH2N, 4 H), 3.48 (m, OMe, 3 H), 
6.65 (s, H-4/5, 2 H), 6.78 (br. s, H-1/8, 2 H), 7.44–7.50 (m, H-3', 1 H), 7.58–7.64 (m, H-6', 1 H), 7.66–7.74 (m, H-4'/5', 2 H), 
8.79 (br. s, NH, 2 H). ESI-MS, positive mode, m/z (C31H31N3O4): 510.5 [M + H]+. HR-MS (ESI, positive mode): calcd: 
510.2387; found 510.2384 [M + H]+. 
 
Compound 1i: To compound 1e[1] (0.68 M solution in N,N-dimethylacetamide, 44 µL, 30 μmol) was added Et3N (4.0 μL, 29 
μmol) followed by 4-tBuO,NH2[2] (10 mg, 28 μmol), and the mixture was stirred at room temperature for 2 days. The solvent 
was evaporated in vacuo at ambient temperature, and the title product was isolated by chromatography on SiO2 (30 g) eluting 
with CH2Cl2/MeOH (8:1, v/v), yield 17 mg (58%). ESI-MS, positive mode, m/z (C52H72N4O12S2): 1053.4 [M – H + 2Na]+, 
negative mode: 1007.5 [M – H]–, 1029.5 [M – 2H + Na]–. 
 
Compound 1j: To a solution of 1i (17 mg, 17 μmol) in trifluoroacetic acid (5.0 mL), was added at 0 ºC triethylsilane (1.0 g, 
1.38 mL, 8.7 mmol), and the mixture was stirred at room temperature for 1 day. The solvent was evaporated in vacuo at 
ambient temperature, and the title product was isolated by chromatography on SiO2 (20 g) eluting with CH2Cl2/MeOH (8:1, 
v/v), yield 7 mg (52%) of a red-purple solid. ESI-MS, positive mode, m/z (C48H64N4O6): 793.6 [M + H]+, 815.5 [M + Na]+, 
negative mode: 791.5 [M – H]–. HR-MS (ESI, positive mode): calcd: 793.4899; found 793.4896 [M + H]+. 
 
Methyl Ester 1k: To compound 1g (50 mg, 0.08 mmol) dissolved in anhydrous DMAA (5 mL), di(N-succinimidyl) 
carbonate (45 mg, 0.17 mmol) and Et3N (0.17 mL, 1.20 mmol) were added under N2 with stirring. The reaction mixture was 
left at room temperature for 1 h. Then 4-MeO,NH2*HCl (84 mg, 0.24 mmol) was added, and the reaction mixture was stirred 
at room temperature for 48 h. The volatile materials were removed under reduced pressure, and the residue was purified by 
column chromatography on SiO2 (50 mL), eluting with CH2Cl2/MeOH (5:1) to yield the title compound (70 mg, 91%) as a 
red powder. 1H NMR (CDCl3, 300 MHz): δ = 0.85 (t, 3H, Me), 1.22 (m, 28 H, 14×CH2, H-4′′′ to H-17′′′), 1.70 (m, 2 H, CH2-
3′′′), 1.85 (s, 4 H, 2×CH2, H-3/9), 2.65 (m, 9 H, NMe and 3×CH2, H-1′′ and H-4/8), 3.10–3.65 (m, 6 H, 3×CH2, H-2′′ and H-
2/10), 3.70 (m, 3 H, MeO), 4.20 (m, 1 H, CH-2′′′), 5.94 (m, 1 H, NH-CO), 6.72–6.87 (m, 2 H, CH-5/7), 7.36 (m, 1 H, CH-6′), 
7.50–7.70 (m, 3 H, 3×CH, H-3′/4′/5′), 9.80–10.00 (m, 2 H, 2×NH) ppm. 13C NMR (CDCl3, 125.7 MHz): δ = 14.0 (Me), 19.0 
(2×CH2, C-3/9), 23.0 (CH2), 25.5 (CH2), 28.0 (2×CH2, C-4/8), 29.5 (CH2), 32.0 (CH2), 39.5 (NMe), 42.6 (2×CH2, C-2/10), 
47.0 (CH2-1′′), 51.3 (OMe), 53.0 (CH-2′′′), 62.5 (CH2-2′′), 111.5 (C), 111.7 (C), 112.3 (C), 112.7 (C), 124.3 (C), 127.9 (CH), 
129.2 (CH), 129.6 (CH), 130.0 (CH), 130.3 (CH), 130.6 (CH), 136.5 (C), 151.6 (C), 152.2 (C), 152.7 (C), 154.7 (C), 156.4 
(CO), 168.0 (CO), 174.0 (CO) ppm. ESI-MS, negative mode, m/z (rel. int., %): 965 (100) [M – H]–, positive mode, m/z (rel. 
int., %): 1011 (100) [M – H + 2Na]+. HR-MS (ESI, positive mode): found: 967.4185, 984.4452, and 989.4002; calcd. for 
C49H66N4O12S2: 967.4191 [M + H]+, 984.4457 [M + NH4]+, and 989.4011 [M + Na]+. 
 
Acid 1l: To a suspension of the methyl ester 1k (50 mg, 0.05 mmol) in anhydrous THF (20 ml), was added dry LiI (60 mg, 
0.45 mmol), and the mixture was heated under reflux in a closed tube (ALDRICH, “Ace Glass” polymerization tube) at 100 
°C (bath) for 48 h and cooled to room temperature. TFA (4 μL, 0.05 mmol) was then added, the solvent was removed under 
reduced pressure, and the residue was purified by preparative TLC (silica gel) eluting with CH2Cl2/MeOH (3:1) to yield the 
title compound (28 mg, 57%) as a red powder. 1H NMR ([D6]-DMSO, 300 MHz): δ = 0.85 (t, 3 H, Me), 1.23 (m, 28 H, 
14×CH2, H-4′′′ to H-17′′′), 1.41–1.70 (m, 4 H, 2×CH2, H-3/9), 1.78 (m, 2 H, CH2-3′′′), 2.59 (s, 1 H, NMe), 2.60–2.81 (m, 4 
H, 2×CH2, H-4/8), 2.88–3.03 (m, 2 H, CH2-1′′), 3.10–3.45 (m, 2 H, CH2-2′′), 3.48–3.63 (m, 4 H, 2×CH2, H-2/10), 3.90 (m, 1 
H, CH-2′′′), 5.35 (m, 1 H, NH-CO), 6.68–6.84 (m, 2 H, CH-5/7), 7.28–7.52 (m, 3 H, 2×CH, H-4′/5′), 7.59–7.74 (m, 2 H, 
2×CH, H-3′/6′), 10.16–10.28 (m, 2 H, 2×NH) ppm. 13C NMR ([D6]-DMSO, 125.7 MHz): δ = 13.8 (Me), 19.0 (2×CH2, C-
3/9), 22.0 (CH2), 25.1 (CH2), 27.2 (2×CH2, C-4/8), 28.9 (CH2), 31.2 (CH2), 41.6 (2×CH2, C-2/10), 54.7 (CH-2′′′), 59.2 (CH2-
2′′), 112.1 (C), 112.8 (C), 116.1 (C), 118.4 (C), 124.1 (C), 128.6 (CH), 128.7 (CH), 129.4 (CH), 130.3 (CH), 145.5 (C), 151.3 
(C), 151.6 (C), 157.5 (C), 157.8 (CO), 167.5 (CO), 174.0 (CO) ppm. ESI-MS, negative mode, m/z (rel. int., %): 951 (100) [M 
– H]–, positive mode, m/z (rel. int., %): 997 (100) [M – H + 2Na]+. HR-MS (ESI, positive mode): found: 953.4031, 975.3854; 
calcd. for C48H64N4O12S2: 953.4035 [M + H]+, 975.3854 [M + Na]+. 
 
Compound 2-OH: To a stirred solution of 20 (5.6 mg, 0.01 mmol) in anhydrous DMF (0.2 mL), 
was added N-metylaminoethanol (20 μL), and the mixture was stirred at room temperature for 12 h. 
The solvent was evaporated under reduced pressure, and the title product was isolated by 
chromatography on SiO2 (20 mL) eluting with CH2Cl2/MeOH (10:1). Yield: 5.7 mg (92%) of a 
violet solid. 1H NMR (300 MHz, CD3OD): δ = 1.90–2.02 (m, 4 H, CH2), 2.03–2.15 (m, 4 H, CH2), 
2.66–2.88 (m, 4 H, CH2C), 2.98–3.12 (m, 7 H, CH3N and CH2C), 3.25–3.34 (m, 4 H, CH2O, CH2N), 
3.46–3.58 (m, 6 H, CH2N), 3.72 (t, J = 5.8, 2 H, CH2N), 6.88 (s, 2 H, CH) ppm. 19F NMR (282.4 MHz, CD3OD): δ = –120.1 
(t, J = 10, 1F), –143.1 (dd, J = 5 and 20, 1F), –144.8 (dd, J = 12 and 20, 1F) ppm. ESI-MS, positive mode, m/z (rel. int., %): 








Compound 2-OCONHS: The compound 2-OH (6.2 mg, 0.01 μmol) was stirred with di(N-
succinimidyl) carbonate (25.6 mg, 0.10 μmol) and NEt3 (25 μL) in anhydrous DMF (1 mL) at 
room temperature for 3 h. The title product was isolated by preparative HPLC (A/B: 60/40 → 
100/0 in 25 min, detection at 254 nm, tR = 6.5 min). ESI-MS, positive mode, m/z (rel. int., 
%): 759.3 [M]+ (100). HR-MS (ESI, positive mode): found: 759.2634; calcd. for 













Compound 3-OH: To a solution of compound 21 (65.4 mg, 0.1 mmol) and NEt3 (50 μL) in 
anhydrous DMF (1 mL), was added HATU (76.0 mg, 0.2 mmol) followed by N-
methylaminoethanol (80 μL, 1.0 mmol), and the mixture was stirred at 50 ºC for 24 h. After 
evaporation of the solvent under reduced pressure, the title compound was isolated by 
chromatography on SiO2 (70 mL) eluting with MeOH/Et2O (1:1 + 0.5% NEt3). Yield: 45 mg 
(61%) of a violet powder. 1H NMR (300 MHz, D2O): δ = 1.62 (s, 6 H, CH3), 1.68 (s, 6 H, CH3), 2.71/2.79 (s, 3 H, NCH3), 
3.05–3.11 (m, 2 H, NCH2), 3.26 (s, 6 H, NCH3), 3.38 (m, 2 H, CH2O), 3.80–3.91 (m, 2 H, CH2S), 3.99–4.10 (m, 2 H, CH2S), 
6.07 (s, 2 H, CH=), 6.85 (s, 2 H, CH), 7.28 (s, 2 H, CH), 7.62–7.70 (s, 1 H, CH), 7.76–7.83 (s, 1 H, CH), 7.90–8.00 (s, 2 H, 
CH) ppm. ESI-MS, negative mode, m/z (rel. int., %): 734.4 [M – H]– (100). HR-MS (ESI, positive mode): found: 736.2356; 







Compound 3-OCONHS: The compound 3-OH (37 mg, 0.05 mmol) was stirred with 
di(N-succinimidyl) carbonate (51 mg, 0.2 mmol) and NEt3 (0.1 mL) in anhydrous DMF 
(0.6 mL) at room temperature for 1 h. The product was isolated by preparative HPLC 
(A/B: 20/80 → 50/50 in 25 min, detection at 254 nm, tR = 11.5 min). ESI-MS, negative 
mode, m/z (rel. int., %): 875.3 [M – H]– (100). HR-MS (ESI, positive mode): found: 













tBuO,NHFmoc):[3] To a cold solution of tert-butyl (2R/S)-aminostearate (0.142 
g, 0.40 mmol) in 1,4-dioxane (8 mL), was added in small portions FmocCl 
(0.124 g, 0.48 mmol) followed by NaHCO3 (0.2 g). The reaction mixture was stirred at room temperature for 24 h, diluted 
with EtOAc (50 mL), washed with water (2×20 mL) and dried. Concentration under reduced pressure afforded an oil, which 
was dissolved in CH2Cl2 (5 mL), and the solution was filtered through silica gel (50 mL) to afford the title compound (0.15 g, 







OH,NHFmoc):[3] To a solution of 4-tBuO,NHFmoc (0.145 g, 0.25 mmol) in 
CH2Cl2 (0.5 mL), were added at 0 °C Et3SiH (50 μL) and TFA (0.5 mL), and the 
mixture was kept at 4 °C for 20 h. Evaporation in vacuo gave the title compound as an oil (0.125 g, 96%). HR-MS (ESI, 





18-Hydroxyoctadecanoic Acid (10a): A solution of the acid 9 (1.3 g, 4.4 mmol) in Et2O (120 mL) was hydrogenated with H2 
(1 atm) over PtO2 (65 mg) at room temperature for 3 h, filtered through Celite®, and concentrated to give the title compound 
(1.3 g, 99%) as a colorless solid with m. p. 99–100 ºC (91–93 ºC,[4] 95–96 ºC[5]). 
 
18-Bromooctadecanoic Acid (10b): To a solution of 10a (0.6 g, 2.0 mmol) in AcOH (9.4 mL), was added 48% aqueous HBr 
(9.4 mL), and the mixture was refluxed for 18 h. Solvents were evaporated in vacuo, and the product was filtered through 


















Figure A. High performance thin layer chromatography (HPTLC) of fluorescent labelled gangliosides presented in the Schemes 3, 5, and 8. 
Lane 1: natural ganglioside GM1; lane 2: product 5; lane 3: product 23a; lane 4: product 17b; lane 5: product 23b; lane 6: product 17a. 
Solvent system: chloroform/methanol/15 mM CaCl2 (60:35:8 v/v). Lane 1 was visualized by treatment with an anisaldehyde reagent 
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